DRMA - Dermata Therapeutics Inc
Dermata Therapeutics Inc Logo

DRMA - Dermata Therapeutics Inc

https://www.dermatarx.com
Recent News
Powered by Alpha Vantage

No recent news found.

AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

None

52W High
$24.90
52W Low
$5.09

MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.56
Valuation
Attractive
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
0.25
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
0.58
EV/Revenue (<3 favorable)
N/A
P/S (TTM) (<3 favorable)
N/A
P/B (<3 favorable)
0.64
Ownership
Retail‑heavy
Source: Overview
Insiders (1–5% typical)
17.00%
Institutions (25–75% balanced)
7.46%
Shares Outstanding
681,560
Float
498,470
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
0
Gross Profit (TTM)
0
EPS (TTM)
20.96
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
N/A
ROE (TTM) (>15% strong)
-2.31%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
N/A
Momentum
Value
N/A
Previous
N/A
Trend
Signal Cross
No cross

As of